Crohn’s Disease Treatment in India: Complete IBD Care Guide for International Patients (2026)
Filters & Insights
Advanced Crohn's disease treatment in India: biologics, surgery, and specialist IBD care at 80% lower cost than the USA. Complete guide for international patients.
AI Overview Summary Box
Crohn’s Disease Treatment in India — Key Facts
- Biologics available: infliximab, adalimumab, vedolizumab, ustekinumab (biosimilars)
- Annual biologic cost in India: USD 2,500–6,000 (vs USD 30,000–60,000 in USA)
- Surgery cost (laparoscopic resection): USD 3,500–5,500
- Leading IBD centers: Delhi, Mumbai (Tata Memorial), Hyderabad (AIG), Chennai, Bangalore
- No waiting lists for specialist consultation
- Treat-to-target protocols followed at top centers
- International patient support: visa, accommodation, telemedicine follow-up
Crohn’s Disease Treatment in India
Crohn’s disease treatment in India combines medication, advanced biologic therapy, endoscopic procedures, and surgery when needed managed by specialized gastroenterologists at India’s top digestive disease centers. International patients choose India because access to biologics (infliximab, adalimumab, vedolizumab) is available at 60–80% lower cost than the USA or UK, waiting times are short, and leading IBD specialists follow international treatment protocols. Most patients achieve remission with medical management; surgery is reserved for complications that do not respond to therapy.
| Treatment Category | Available in India | Approximate Cost (USD) |
|---|---|---|
| Specialist IBD Consultation | ✓ Yes | $30 – $80 |
| Diagnostic Colonoscopy with Biopsy | ✓ Yes | $150 – $350 |
| MRI Enterography | ✓ Yes | $150 – $300 |
| Biologic Therapy (Per Infusion / Injection) | ✓ Yes | $300 – $900 |
| Laparoscopic Bowel Resection | ✓ Yes | $3,500 – $6,500 |
| Total Colectomy (If Required) | ✓ Yes | $4,000 – $7,500 |
Key Takeaways
- Crohn’s disease cannot be cured but can be effectively managed — most patients achieve remission with appropriate treatment
- Biologic therapy is the most effective medical treatment for moderate to severe Crohn’s disease; biosimilars in India cost 85–92% less than in the USA
- Surgery treats complications (strictures, fistulas, abscesses) but does not cure the underlying disease
- India’s top gastroenterology centers follow international treat-to-target protocols with access to the full biologic range
- Shifam Health provides end-to-end support from medical report review to post-treatment follow-up
What Is Crohn’s Disease?
Crohn’s disease is a chronic inflammatory bowel disease (IBD) that can affect any part of the digestive tract, most commonly the small intestine and the beginning of the large intestine.
Unlike ulcerative colitis, Crohn’s disease can affect all layers of the bowel wall, leading to complications such as strictures (narrowing of the intestine), fistulas, and abscesses.
The condition occurs when the immune system mistakenly attacks the digestive tract, causing ongoing inflammation. Symptoms often alternate between flare-ups and periods of remission.
Crohn’s disease affects people of all ages and backgrounds. While historically more common in Western countries, diagnoses are rising across the Middle East, South Asia, and Africa meaning international patients increasingly require access to advanced IBD care.
Crohn’s Disease Symptoms
Symptoms range from mild to severely debilitating and vary by location and extent of bowel involvement.
Gastrointestinal Symptoms
| Symptom | Description |
|---|---|
| Persistent Diarrhea | Often occurs multiple times daily and may exceed six bowel movements per day during active disease flares. |
| Abdominal Pain and Cramping | Commonly felt in the lower right abdomen or central abdominal region, depending on the area of bowel involvement. |
| Blood in Stool | May result from intestinal inflammation, ulceration, or bleeding within the digestive tract. |
| Mucus in Stool | Often indicates active inflammation affecting the lining of the intestine. |
| Urgency to Defecate | A sudden and difficult-to-control need to pass stool, frequently occurring after meals. |
| Nausea and Vomiting | May occur during severe disease flares, bowel narrowing, or intestinal obstruction. |
| Weight Loss | Can result from reduced appetite, chronic inflammation, nutrient malabsorption, and increased metabolic demands. |
| Bloating and Gas | Often caused by intestinal inflammation, altered gut motility, or partial bowel obstruction. |
Systemic Symptoms
| Symptom | Description |
|---|---|
| Fatigue | Often chronic and sometimes severe, resulting from ongoing inflammation, anemia, poor nutrient absorption, and the body’s increased energy demands during active disease. |
| Fever | May occur during active inflammatory bowel disease flares or when complications such as abscesses and infections are present. |
| Night Sweats | Can develop during periods of significant inflammation or active disease activity. |
| Anemia | Commonly caused by chronic blood loss, iron deficiency, vitamin deficiencies, and impaired nutrient absorption from the intestine. |
| Nutritional Deficiencies | Patients may develop deficiencies of vitamin B12, vitamin D, iron, zinc, folate, and other essential nutrients due to malabsorption and reduced dietary intake. |
| Growth Delay in Children | Chronic inflammation, poor nutrition, and inadequate calorie absorption can affect normal growth and physical development. |
Extra-Intestinal Manifestations
| System Affected | Common Symptoms and Conditions |
|---|---|
| Joints | Arthritis, joint pain, stiffness, and swelling, particularly affecting large joints such as the knees and ankles. |
| Skin | Erythema nodosum (painful red nodules, usually on the legs) and pyoderma gangrenosum (rare inflammatory skin ulcers). |
| Eyes | Uveitis and episcleritis, which may cause eye redness, pain, light sensitivity, blurred vision, and irritation. |
| Liver and Bile Ducts | Primary sclerosing cholangitis (PSC), a chronic inflammatory condition affecting the bile ducts, seen more commonly in patients with ulcerative colitis. |
| Mouth | Aphthous ulcers (canker sores), oral pain, and recurrent mouth ulcers that may flare alongside intestinal disease activity. |
Red-Flag Symptoms: Seek Immediate Care
| Emergency Warning Sign | What It May Indicate |
|---|---|
| Sudden Severe Abdominal Pain | May indicate bowel perforation, intestinal obstruction, toxic megacolon, or another surgical emergency requiring immediate medical evaluation. |
| High Fever with an Abdominal Mass | Can suggest abscess formation, severe infection, or advanced inflammatory complications that may require drainage or urgent treatment. |
| Complete Inability to Pass Stool or Gas | May be a sign of intestinal obstruction caused by severe inflammation, strictures, adhesions, or bowel narrowing. |
| Significant Rectal Bleeding | May indicate severe intestinal ulceration, active disease flare, or substantial blood loss requiring urgent assessment. |
| Passage of Stool Through the Skin or Vagina | Strongly suggests fistula development, a serious complication more commonly associated with Crohn’s disease. |
Causes and Risk Factors
Crohn’s Disease vs Ulcerative Colitis: Key Differences
Both conditions are forms of inflammatory bowel disease, but they are distinct diagnoses with different patterns, complications, and treatment approaches. Correct diagnosis determines the treatment plan.
| Feature | Crohn’s Disease | Ulcerative Colitis |
|---|---|---|
| Location in GI Tract | Can affect any part of the digestive tract from the mouth to the anus | Limited to the colon (large intestine) and rectum |
| Distribution Pattern | Patchy involvement with “skip lesions” separated by healthy bowel | Continuous inflammation beginning in the rectum and extending upward |
| Depth of Inflammation | Transmural inflammation involving all layers of the bowel wall | Inflammation primarily affects the inner mucosal lining |
| Most Commonly Affected Region | Terminal ileum (end of the small intestine) | Rectum and sigmoid colon |
| Rectal Involvement | Present in some patients but not universal | Almost always present |
| Blood in Stool | Less consistent and may be absent | Very common, especially during active flares |
| Fistulas | Common complication due to deep bowel wall inflammation | Rare |
| Strictures (Bowel Narrowing) | Common because of chronic scarring and inflammation | Uncommon |
| Effect of Surgery | Surgery treats complications but is not curative; disease may recur | Total colectomy can be curative in many patients |
| Risk of Colorectal Cancer | Elevated, depending on disease extent and duration | Elevated, particularly in extensive pancolitis |
| Smoking Effect | Generally worsens disease activity and complications | May appear mildly protective, but smoking is never recommended due to overall health risks |
| Response to Biologic Therapy | Often responds well to biologic medications | Often responds well to biologic medications |
| Malabsorption Risk | More common, especially with small bowel involvement | Less common |
How Crohn’s Disease Is Diagnosed
Diagnosis requires combining clinical assessment with laboratory tests, imaging, and endoscopy. No single test confirms Crohn’s disease; the diagnosis is built from multiple sources of evidence.
- Specialist Consultation
A gastroenterologist takes a thorough history of symptoms, duration, family history, and prior treatments. Physical examination may reveal abdominal tenderness, perianal disease, or signs of malnutrition.
- Blood Tests
Full blood count (FBC): checks for anemia, elevated white cells
CRP and ESR: inflammatory markers elevated during active disease
Albumin and ferritin: nutritional status
Liver function tests
Vitamin B12, D, folate, zinc levels - Stool Tests
Fecal calprotectin: highly sensitive marker of intestinal inflammation; distinguishes IBD from irritable bowel syndrome (IBS)
Stool cultures: to rule out infectious causes of diarrhea
C. difficile testing - Colonoscopy with Biopsy
The most important diagnostic procedure. The gastroenterologist examines the colon and terminal ileum, takes multiple biopsies, and assesses the pattern of inflammation. In Crohn’s, cobblestone mucosal appearance, deep ulcers, and skip lesions are characteristic findings.
- Cross-Sectional Imaging
MRI enterography: the preferred method for assessing small bowel Crohn’s disease. No radiation, excellent soft tissue detail, shows bowel wall thickness, strictures, and fistulas
CT enterography: used when MRI is unavailable or in emergency settings
Ultrasound: useful for monitoring bowel wall thickness, particularly in children - Capsule Endoscopy
A small wireless camera in a capsule is swallowed by the patient and photographs the small intestine as it passes through. Used when conventional endoscopy cannot reach affected areas. Not appropriate when bowel strictures are suspected.
Crohn’s Disease Treatment in India: Overview
The goals of treatment for Crohn’s disease are:
- Induce remission — bring active inflammation under control
- Maintain remission — prevent future flare-ups
- Heal the intestinal mucosa — not just symptom control, but actual tissue healing
- Prevent complications — fistulas, strictures, malnutrition, cancer
- Improve quality of life — return to normal daily activities
India’s gastroenterology centers approach IBD using the same international treatment algorithms followed at leading centers in Europe and the USA including the treat-to-target strategy endorsed by the European Crohn’s and Colitis Organization (ECCO) and the American Gastroenterological Association.
Treatment is stepped based on disease severity:
| Disease Activity | Initial Treatment Approach |
|---|---|
| Mild Crohn’s Disease (Ileocecal Region) | Oral budesonide is commonly used to control localized inflammation affecting the terminal ileum and cecum while minimizing systemic steroid exposure. |
| Mild to Moderate Crohn’s Disease | Treatment may include 5-ASA agents (selected cases), antibiotics, nutritional therapy, dietary modification, and close monitoring of symptoms and inflammatory markers. |
| Moderate Crohn’s Disease | Systemic corticosteroids may be used for flare control, followed by immunomodulators such as azathioprine or 6-mercaptopurine (6-MP) for long-term disease management. |
| Moderate to Severe Crohn’s Disease | Biologic therapies are frequently recommended, including anti-TNF agents, vedolizumab, or ustekinumab, particularly when conventional medications fail to achieve remission. |
| Severe or Complicated Crohn’s Disease | May require combination therapy using biologics and immunomodulators, hospitalization, nutritional support, drainage of abscesses, or surgery for strictures, fistulas, perforation, or bowel obstruction. |
Crohn’s Disease Treatment Options
Medications
- Aminosalicylates (5-ASA): Sometimes used for mild Crohn’s disease affecting the colon.
- Corticosteroids: Prednisone, prednisolone, and budesonide help control flare-ups quickly but are not suitable for long-term use.
- Immunomodulators: Azathioprine, 6-MP, and methotrexate help maintain remission by suppressing immune activity.
- Antibiotics: Ciprofloxacin and metronidazole may be used for fistulas, abscesses, and perianal Crohn’s disease.
- Nutritional Therapy: Special diets and enteral nutrition can help induce remission and improve nutrition.
Advanced Biologic Therapy
Biologics target specific inflammatory pathways and are often used for moderate to severe Crohn’s disease.
- Infliximab (Remicade® and biosimilars): Given by IV infusion and effective for both intestinal and fistulizing Crohn’s disease.
- Adalimumab (Humira® and biosimilars): Self-injected medication offering convenient long-term treatment.
Biologics can achieve deep remission, promote intestinal healing, and reduce the need for surgery in many patients.
| Feature | Infliximab | Adalimumab |
|---|---|---|
| Route of Administration | Intravenous (IV) infusion administered in a hospital or infusion center | Subcutaneous injection that can usually be self-administered at home |
| Maintenance Frequency | Typically every 8 weeks after induction therapy | Typically every 2 weeks during maintenance treatment |
| Effectiveness for Fistulas | Strong clinical evidence, particularly for complex perianal fistulas | Good evidence and commonly used when long-term home administration is preferred |
| Immunogenicity (Antibody Formation) | Can occur and may reduce treatment effectiveness over time | Can occur and may affect long-term response |
| Monitoring Requirements | Therapeutic drug monitoring, trough levels, CRP, and clinical assessment may be required | Therapeutic drug monitoring, trough levels, CRP, and clinical assessment may be required |
| Approximate Cost in India (Biosimilar) | $300 – $700 per infusion | $200 – $500 per injection |
Advanced Biologic Therapies for Crohn’s Disease
For moderate to severe Crohn’s disease, biologic therapies target specific inflammatory pathways and can achieve long-term remission and intestinal healing.
- Vedolizumab (Entyvio®): A gut-selective biologic that reduces intestinal inflammation with a lower risk of systemic infections. Often used after anti-TNF treatment failure.
- Ustekinumab (Stelara®): Targets IL-12 and IL-23 inflammatory pathways. Given as an IV induction dose followed by periodic injections.
- Risankizumab (Skyrizi®): A newer IL-23 inhibitor showing strong results in patients with moderate to severe Crohn’s disease.
- Upadacitinib: An oral JAK inhibitor used for patients with moderate to severe disease who need advanced medical therapy.
Common Biologic Treatment Costs in India
| Treatment | Best For | Approximate Cost |
|---|---|---|
| Infliximab (Biosimilar) | Moderate-to-severe Crohn’s disease, fistulizing disease, steroid-dependent patients, and those requiring rapid control of inflammation. | USD 300–700 per dose |
| Adalimumab (Biosimilar) | Patients preferring home-based treatment with self-administered injections and long-term maintenance therapy. | USD 200–500 per dose |
| Vedolizumab | Gut-selective biologic therapy for patients who have inadequate response to conventional treatment or who need a targeted gastrointestinal approach. | USD 500–900 per dose |
| Ustekinumab | Patients with moderate-to-severe Crohn’s disease, particularly after failure or intolerance of anti-TNF therapy. | USD 400–800 per dose |
| Risankizumab | Advanced Crohn’s disease with persistent inflammation despite previous biologic treatment or complex disease behavior. | USD 500–900 per dose |
| Upadacitinib | Advanced oral therapy option for selected patients who require a non-injection, non-infusion treatment approach. | USD 400–700 per month |
Regular monitoring and follow-up help optimize treatment response and ensure long-term disease control.
Surgery for Crohn’s Disease
Surgery does not cure Crohn’s disease unlike in ulcerative colitis, the disease can return after bowel resection. However, surgery plays a critical role in managing complications that do not respond to medical therapy.
When is surgery necessary?
- Bowel obstruction from stricture that cannot be dilated endoscopically
- Abscess not controlled by antibiotics and drainage
- Fistula causing significant symptoms or complications
- Bowel perforation
- Failure of medical therapy with deteriorating quality of life
- Crohn’s disease-associated cancer
- Growth failure in children unresponsive to medical treatment
Types of Surgery
Strictureplasty Rather than removing bowel, the surgeon widens a narrowed (strictured) segment by making a lengthwise incision and sewing it across. This preserves bowel length critical for avoiding short bowel syndrome. Performed laparoscopically in experienced centers.
Laparoscopic Bowel Resection The most common surgical procedure. The diseased segment is removed and the healthy ends rejoined (anastomosis). Laparoscopic approach results in faster recovery, less pain, and shorter hospital stay.
Fistula Surgery Fistulas (abnormal connections between bowel and other structures) require careful surgical assessment. Simple fistulas can be treated with seton placement (a surgical thread to promote drainage). Complex fistulas may need combined medical and surgical management.
Abscess Drainage Abscesses adjacent to the bowel are drained either radiologically (percutaneous CT-guided drainage) or surgically. Antibiotics and biologic therapy often follow.
Colectomy For patients with Crohn’s colitis unresponsive to all medical therapies, colectomy (removal of the colon) may be recommended.
| Surgery Type | Purpose | Laparoscopic Option | Typical Hospital Stay |
|---|---|---|---|
| Strictureplasty | Widens narrowed segments of bowel caused by chronic inflammation and scarring while preserving bowel length. | Yes | 3–5 Days |
| Ileocecal Resection | Removes the diseased terminal ileum and cecum, the most commonly affected area in Crohn’s disease. | Yes | 3–5 Days |
| Laparoscopic Colectomy | Removes severely diseased portions of the colon when medical therapy is no longer effective or complications develop. | Yes | 4–7 Days |
| Fistula Repair | Closes abnormal connections between the intestine and nearby organs, skin, or other structures. | Yes (Selected Cases) | 3–7 Days |
| Abscess Drainage | Controls infection by draining collections of pus associated with Crohn’s disease complications. | Usually Image-Guided (Radiological) | 3–5 Days |
Crohn’s Disease Treatment Cost in India
One of the primary reasons international patients seek IBD care in India is cost. Both diagnostics and therapy — including biologics — are available at a fraction of Western prices.
Diagnostic Costs
| Investigation | India Cost (USD) |
|---|---|
| IBD Specialist Consultation | $30 – $80 |
| Full Blood Panel (CBC, CRP, ESR, Liver & Kidney Function Tests) | $40 – $90 |
| Fecal Calprotectin | $30 – $60 |
| Colonoscopy with Biopsy | $150 – $350 |
| MRI Enterography | $200 – $350 |
| CT Enterography | $150 – $280 |
| Capsule Endoscopy | $400 – $700 |
| Genetic Testing (Selected Cases) | $200 – $500 |
Medical Treatment Costs (Annual Estimates)
| Therapy | India Cost (USD/Year) | USA Cost (USD/Year) | Estimated Savings |
|---|---|---|---|
| Azathioprine (Immunomodulator) | $200 – $500 | $2,000 – $5,000 | 80–90% |
| Infliximab Biosimilar (6 Infusions) | $2,500 – $4,500 | $30,000 – $50,000 | 85–92% |
| Adalimumab Biosimilar (26 Injections) | $2,000 – $4,000 | $25,000 – $40,000 | 88–92% |
| Vedolizumab (Maintenance Therapy) | $3,500 – $6,000 | $40,000 – $60,000 | 88–92% |
| Ustekinumab (Maintenance Therapy) | $3,000 – $5,500 | $40,000 – $55,000 | 87–92% |
Surgical Costs
| Procedure | India Cost (USD) |
|---|---|
| Laparoscopic Ileocecal Resection | $3,500 – $5,500 |
| Strictureplasty | $2,500 – $4,500 |
| Laparoscopic Colectomy | $4,000 – $7,500 |
| Fistula Repair | $2,000 – $4,500 |
| Abscess Drainage (Image-Guided / Radiological) | $500 – $1,500 |
Costs in Multiple Currencies
| Currency | Infliximab Biosimilar (6 Infusions) | Laparoscopic Resection |
|---|---|---|
| USD | $2,500–$4,500 | $3,500–$5,500 |
| GBP | £1,950–£3,500 | £2,700–£4,300 |
| EUR | €2,300–€4,150 | €3,200–€5,100 |
| AED | AED 9,200–16,500 | AED 12,900–20,200 |
| SAR | SAR 9,375–16,875 | SAR 13,125–20,625 |
| BDT | BDT 2,75,000–4,95,000 | BDT 3,85,000–6,05,000 |
Why International Patients Choose India for Crohn’s Disease Treatment
Cost Comparison
| Country | Annual Biologic Therapy Cost (Approx.) | Compared to India |
|---|---|---|
| USA | $30,000 – $60,000 | 8–12× more expensive |
| UK (Private) | $20,000 – $40,000 | 5–8× more expensive |
| UAE | $12,000 – $20,000 | 3–4× more expensive |
| Turkey | $5,000 – $9,000 | 1.5–2× more expensive |
| Thailand | $6,000 – $10,000 | 1.5–2× more expensive |
| India | $2,500 – $6,000 | Baseline |
Beyond Cost
IBD subspecialists. India’s leading IBD centers have gastroenterologists with dedicated training in inflammatory bowel disease not generalists covering all GI conditions. These specialists manage complex refractory IBD, conduct therapeutic drug monitoring, and have experience with the full range of biologic therapies.
Multidisciplinary approach. The best Indian centers offer integrated care: gastroenterologist, colorectal surgeon, clinical dietitian, radiologist, and pathologist working together on IBD cases — the same model used at IBD centers of excellence in the UK and USA.
Access to biosimilars. India is one of the most competitive biologic markets globally. High-quality biosimilars of infliximab, adalimumab, and vedolizumab are approved and widely used, making treatment financially sustainable.
No waiting lists. In NHS England, patients can wait 6–12 weeks or longer for specialist IBD consultation. In India, appointments with leading gastroenterologists are available within days.
Best Hospitals in India for Advanced IBD Treatment
When evaluating a hospital for Crohn’s disease treatment, the criteria that matter most for complex IBD include:
- Dedicated IBD clinic with subspecialist gastroenterologists
- Advanced endoscopy unit (colonoscopy, capsule endoscopy, enteroscopy)
- MRI enterography capability
- Access to the full range of biologic and small molecule therapies
- Therapeutic drug monitoring laboratory
- Colorectal surgery backup for surgical complications
- Clinical nutrition and dietetic support
- International patient coordination services
Hospitals that meet these criteria in India include those within the Apollo, Fortis, Medanta, Manipal, Max, and Kokilaben networks, as well as specialist centers such as Asian Institute of Gastroenterology (AIG) in Hyderabad.
Shifam Health evaluates hospitals based on your specific disease pattern location of disease, prior treatment history, complexity, and surgical risk and recommends the center best matched to your needs.
Recovery and Long-Term Disease Management
Crohn’s disease is a lifelong condition. Treatment strategy does not end at remission; it focuses on keeping patients in remission for as long as possible.
After medical treatment in India:
- Trough level monitoring of biologics every 3–6 months
- Colonoscopy every 1–2 years (disease-extent dependent) to assess mucosal healing
- Annual blood tests for nutritional markers, inflammatory markers, blood count
- Bone density scan every 2–3 years if on long-term steroids
- Cancer surveillance colonoscopy after 8–10 years of colonic disease
After surgery in India: Most patients stay 3–5 days in hospital following laparoscopic resection. International patients should plan to remain in India for 14–18 days before traveling home. Your Indian team will provide full discharge summaries and surgical reports for your home physician.
Remission maintenance principles:
- Never stop maintenance therapy without specialist guidance
- Continue biologic therapy even during symptom-free periods — stopping causes relapse
- Address nutritional deficiencies proactively
- Maintain regular exercise; physical activity is associated with reduced relapse rates
- Psychological support — IBD significantly impacts mental health; IBD specialist nurses or psychologists are available at top Indian centers
Crohn’s Disease Diet Guide
Diet does not cause Crohn’s disease, but it profoundly affects symptom experience and nutritional status. Dietary needs change between active disease and remission.
During Flare-Ups
| Dietary Principle | Practical Guidance |
|---|---|
| Reduce Fiber During Active Flares | Avoid raw vegetables, seeds, nuts, popcorn, and whole grains, especially when symptoms are severe or bowel narrowing is present. |
| Stay Hydrated | Chronic diarrhea can lead to significant fluid and electrolyte loss. Drink adequate water, oral rehydration solutions, soups, and electrolyte-containing fluids. |
| Eat Small, Frequent Meals | Smaller meals throughout the day are often easier to digest and may reduce abdominal discomfort and digestive stress. |
| Choose Low-Residue Foods | Examples include white rice, white bread, peeled and well-cooked vegetables, eggs, fish, chicken, and other easily digestible foods. |
| Limit Dairy If Lactose Intolerant | Many Crohn’s disease patients develop secondary lactose intolerance. If dairy worsens symptoms, consider lactose-free alternatives. |
| Avoid Caffeine and Alcohol | Both can increase intestinal motility, aggravate diarrhea, contribute to dehydration, and worsen gastrointestinal symptoms. |
During Remission
| Principle | Practical Guidance |
|---|---|
| Gradually Reintroduce Fiber | Soluble fiber sources such as oats, carrots, bananas, applesauce, and peeled fruits are generally better tolerated and can be reintroduced gradually during remission. |
| Adequate Protein Intake | Protein is essential for tissue repair, immune function, and maintaining muscle mass. Choose lean meat, fish, eggs, poultry, tofu, and legumes if well tolerated. |
| Omega-3 Fatty Acids | May provide anti-inflammatory benefits and are naturally found in oily fish such as salmon, sardines, mackerel, trout, as well as flaxseed and walnuts. |
| Vitamin D Supplementation | Vitamin D deficiency is common in inflammatory bowel disease (IBD). Blood level monitoring and supplementation may be recommended by your healthcare provider. |
| Probiotic Foods | Research is evolving. Some patients may benefit from probiotic-rich foods such as yogurt, kefir, and fermented foods, but specialist guidance is recommended before starting supplements. |
| Identify Personal Trigger Foods | Food triggers vary significantly between individuals. Maintaining a food and symptom diary can help identify foods that worsen symptoms or contribute to disease flares. |
Foods Commonly Reported as Triggers
- Spicy foods
- High-fat or fried foods
- Carbonated drinks
- Alcohol
- Popcorn, nuts, seeds (particularly during stricture)
- Lactose-containing dairy (if intolerant)
- High-insoluble-fiber raw vegetables during flares
Important: There is no universal Crohn’s disease diet. What triggers symptoms in one patient may be well tolerated in another. Dietary guidance should be personalized by a registered clinical dietitian familiar with IBD.
Potential Complications If Left Untreated
Crohn’s disease that is poorly controlled or untreated carries significant risk of serious, life-altering complications.
Fistulas: Transmural inflammation can create abnormal tunnels connecting loops of bowel to each other, the bladder, vagina, or skin. Perianal fistulas are particularly common in Crohn’s disease and can significantly impact quality of life.
Strictures: Repeated cycles of inflammation and healing cause scarring that narrows the intestine, leading to partial or complete bowel obstruction. Strictures can sometimes be dilated endoscopically; severe ones require surgery.
Abscesses: Collections of pus adjacent to the bowel, often requiring drainage and antibiotic therapy.
Malnutrition: Chronic inflammation, malabsorption, reduced appetite, and dietary restriction combine to cause protein-energy malnutrition, vitamin deficiencies, and bone loss (osteoporosis).
Colorectal Cancer: The risk is elevated in long-standing Crohn’s colitis. Regular surveillance colonoscopies allow early detection.
Intestinal Obstruction: Strictures can completely block the bowel, causing severe pain, distension, and vomiting a surgical emergency.
Growth Failure in Children: Chronic undernutrition and systemic inflammation impair growth and puberty in pediatric Crohn’s patients if disease is not adequately controlled.
Addressing these risks is precisely why early, effective treatment and not just symptom management matters so much. The goal of modern IBD care is mucosal healing, which reduces the risk of all these complications.
How Shifam Health Supports Your Crohn’s Disease Journey
When you are living with Crohn’s disease — managing pain, fatigue, dietary restriction, and medical uncertainty — the last thing you need is administrative complexity added to your journey.
Shifam Health removes every obstacle between you and the specialist care you need:
Medical report review: Share your current reports, previous colonoscopy results, and imaging. The Shifam Health clinical team arranges review by an IBD specialist within 48 hours, so you arrive in India with a preliminary treatment plan already in place.
Hospital and specialist matching: Not every hospital that calls itself a gastroenterology center has dedicated IBD expertise. Shifam Health evaluates centers specifically for IBD capability biologic access, therapeutic drug monitoring, surgical backup, and international patient experience.
Treatment cost estimate: Before you commit to travel, you receive an itemized cost estimate covering consultation, diagnostics, treatment, and any likely surgical options no hidden costs.
Medical visa and travel support: Invitation letter from the treating hospital, medical visa application guidance, airport pickup, and accommodation near your hospital.
In-hospital coordination: A Shifam Health coordinator is available during your hospital admission helping with communication, paperwork, and any logistical needs.
Post-treatment follow-up: After you return home, Shifam Health coordinates telemedicine consultations with your Indian IBD team and liaises with your local physician to ensure continuity of care.
Frequently Asked Questions
Can Crohn’s disease be cured?
No. There is no cure, but modern treatments can achieve long-term remission and excellent quality of life.
What is the best treatment for Crohn’s disease?
Treatment depends on disease severity. Mild cases may respond to steroids, while moderate to severe disease often requires biologic therapies such as infliximab, adalimumab, vedolizumab, or ustekinumab.
How much does Crohn’s disease treatment cost in India?
Biologic therapy typically costs USD 2,500–6,000 per year, while surgery for complications ranges from USD 3,500–7,500.
Are biologics available in India?
Yes. Leading hospitals offer infliximab, adalimumab, vedolizumab, ustekinumab, and biosimilar alternatives.
How long do biologics take to work?
Most patients notice improvement within 4–12 weeks, depending on the medication.
Can Crohn’s disease return after surgery?
Yes. Surgery treats complications but does not cure the disease. Ongoing medical therapy helps reduce recurrence.
What foods trigger Crohn’s flare-ups?
Common triggers include spicy foods, high-fat foods, alcohol, caffeine, and high-fiber foods during active disease.
What is the difference between Crohn’s disease and IBS?
Crohn’s disease causes inflammation and bowel damage, while IBS is a functional condition without inflammation.
When is surgery needed for Crohn’s disease?
Surgery may be required for strictures, fistulas, abscesses, bowel obstruction, or when medications no longer control symptoms.
How long should I stay in India for treatment?
Medical treatment usually requires 5–10 days, while surgical treatment typically requires 14–21 days.
Can I get a second opinion before traveling?
Yes. Shifam Health can arrange specialist consultations and second opinions before treatment begins.
Ready to Speak With an IBD Specialist in India?
If you or a family member has been diagnosed with Crohn’s disease and you are not achieving remission, facing unaffordable biologic costs, waiting months for a specialist appointment, or considering surgery you deserve a clear second opinion.
Share your medical reports with Shifam Health today.
Within 48 hours, you receive a written clinical review, specialist recommendation, and detailed cost estimate at no charge.
Whether you need a second opinion on your current treatment, access to biologic therapy at an affordable cost, or surgical management of complications, the Shifam Health team is ready to help you take the next step.
Related Reads
Popular Posts From Last Week
- June 12, 2026
- shifamhealth
If you or someone you love is facing hip replacement surgery, the question that probably keeps you up…
- June 12, 2026
- shifamhealth
Glaucoma is often called the “silent thief of sight” and for good reason. In its early stages, it…
- June 12, 2026
- shifamhealth
If you’ve been living with atrial fibrillation waking up with your heart racing unpredictably, watching medications fail one…
- June 13, 2026
- shifamhealth
Every year, thousands of families face a difficult reality: a loved one has Parkinson’s disease, treatment is available…
- June 14, 2026
- shifamhealth
AI Overview Summary Box Colon removal surgery (colectomy) in India costs between USD 2,500 and USD 8,000, depending…
- June 14, 2026
- shifamhealth
AI Overview Summary Box Crohn’s Disease Treatment in India Crohn’s disease treatment in India combines medication, advanced biologic…
- June 14, 2026
- shifamhealth
Sources: Indian Bureau of Immigration (boi.gov.in), Ministry of Home Affairs (mha.gov.in), Indian Visa Online portal (indianvisaonline.gov.in) What is…
- June 13, 2026
- shifamhealth
If you’re already in India for treatment or planning a procedure that may require a longer recovery period…